ESMO Shares Recommendations to Support Cancer Research and Clinical Trials in Europe By Ogkologos - May 28, 2026 143 0 Facebook Twitter Google+ Pinterest WhatsApp EU Competitiveness Council (Research) Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR The Gift of Time December 8, 2023 Anal Cancer Incidence and Deaths Are Rising in the United States December 19, 2019 New Class of Compounds Rewires Cancer Cells to Self-Destruct August 29, 2023 EMA Recommends Granting a Conditional Marketing Authorisation for Dostarlimab February 26, 2021 Load more HOT NEWS Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Improves EFS and OS in Cisplatin-Eligible... Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard... FDA Updates Safety Labelling for Capecitabine and 5-FU on Risks Associated... UK Clinical Trial Compares E-cigarettes, Nicotine-Replacement Products for Smoking Cessation
